Analysis of protein aggregation in neurodegenerative disease

Analytical Chemistry

Volumn 85, Issue 9, 2013, Pages 4215-4227

  Pedersen, Jeppe T ^a   Heegaard, Niels H H ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CENTRAL NERVOUS SYSTEMS; CREUTZFELDT-JAKOB'S DISEASE; HUNTINGTON'S DISEASE; NEURODEGENERATIVE; PATHOPHYSIOLOGICAL; PEPTIDE AGGREGATION; PROTEIN AGGREGATION;

DISEASE CONTROL; PROTEINS;

NEURODEGENERATIVE DISEASES;

PROTEIN;

ARTICLE; CHEMISTRY; DEGENERATIVE DISEASE; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE;

HUMANS; IMMUNOASSAY; MASS SPECTROMETRY; NEURODEGENERATIVE DISEASES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEINS;

EID: 84877346858     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/ac400023c     Document Type: Article

References (125)

1. Chiti, F.; Dobson, C. M. Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 2006, 75 (333-66) 333-366
2. van Ham, T. J.; Breitling, R.; Swertz, M. A.; Nollen, E. A. Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms EMBO Mol. Med. 2009, 1 (8-9) 360-370
3. Ross, C. A.; Poirier, M. A. Protein aggregation and neurodegenerative disease Nat. Med. 2004, 10 (Suppl) S10-S17
4. Cselenyi, Z.; Jonhagen, M. E.; Forsberg, A.; Halldin, C.; Julin, P.; Schou, M.; Johnstrom, P.; Varnas, K.; Svensson, S.; Farde, L. Clinical validation of 18F-AZD4694, an amyloid-beta-specific PET radioligand J. Nucl. Med. 2012, 53 (3) 415-424
5. Ikonomovic, M. D.; Klunk, W. E.; Abrahamson, E. E.; Mathis, C. A.; Price, J. C.; Tsopelas, N. D.; Lopresti, B. J.; Ziolko, S.; Bi, W.; Paljug, W. R.; Debnath, M. L.; Hope, C. E.; Isanski, B. A.; Hamilton, R. L.; Dekosky, S. T. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Brain 2008, 131 (Pt 6) 1630-1645
6. Wall, J. S.; Richey, T.; Stuckey, A.; Donnell, R.; Macy, S.; Martin, E. B.; Williams, A.; Higuchi, K.; Kennel, S. J. In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (34) E586-E594
7. Hawkins, P. N.; Pepys, M. B. Imaging amyloidosis with radiolabelled SAP Eur. J Nucl. Med. 1995, 22 (7) 595-599
8. Woods, L. A.; Platt, G. W.; Hellewell, A. L.; Hewitt, E. W.; Homans, S. W.; Ashcroft, A. E.; Radford, S. E. Ligand binding to distinct states diverts aggregation of an amyloid-forming protein Nat. Chem. Biol. 2011, 7 (10) 730-739
9. Zheng, X.; Gessel, M. M.; Wisniewski, M. L.; Viswanathan, K.; Wright, D. L.; Bahr, B. A.; Bowers, M. T. Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Abeta42 protein J. Biol. Chem. 2012, 287 (9) 6084-6088
10. Miranker, A.; Robinson, C. V.; Radford, S. E.; Aplin, R. T.; Dobson, C. M. Detection of transient protein folding populations by mass spectrometry Science 1993, 262 (5135) 896-900
11. Brockwell, D. J.; Smith, D. A.; Radford, S. E. Protein folding mechanisms: new methods and emerging ideas [see comments] Curr. Opin. Struct. Biol. 2000, 10 (1) 16-25
12. Sipe, J. D.; Benson, M. D.; Buxbaum, J. N.; Ikeda, S.; Merlini, G.; Saraiva, M. J.; Westermark, P. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis Amyloid 2012, 19 (4) 167-170
13. Robinson, J. L.; Geser, F.; Stieber, A.; Umoh, M.; Kwong, L. K.; Van Deerlin, V. M.; Lee, V. M.; Trojanowski, J. Q. TDP-43 skeins show properties of amyloid in a subset of ALS cases Acta Neuropathol. 2013, 125, 121-131
14. Yamasaki, M.; Li, W.; Johnson, D. J.; Huntington, J. A. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization Nature 2008, 455 (7217) 1255-1258
15. LeVine, H., III Alzheimer's beta-peptide oligomer formation at physiologic concentrations Anal. Biochem. 2004, 335 (1) 81-90
16. Bitan, G.; Fradinger, E. A.; Spring, S. M.; Teplow, D. B. Neurotoxic protein oligomers-what you see is not always what you get Amyloid 2005, 12 (2) 88-95
17. Pedersen, J. T.; Østergaard, J.; Rozlosnik, N.; Gammelgaard, B.; Heegaard, N. H. Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-{beta} peptides J. Biol. Chem. 2011, 286, 26952-26963
18. Pryor, E.; Kotarek, J. A.; Moss, M. A.; Hestekin, C. N. Monitoring Insulin Aggregation via Capillary Electrophoresis Int. J. Mol. Sci. 2011, 12 (12) 9369-9388
19. Picou, R. A.; Schrum, D. P.; Ku, G.; Cerqua, R. A.; Kheterpal, I.; Gilman, S. D. Separation and detection of individual Abeta aggregates by capillary electrophoresis with laser-induced fluorescence detection Anal. Biochem. 2012, 425 (2) 104-112
20. Heegaard, N. H. H.; Sen, J. W.; Nissen, M. H. Congophilicity (Congo red affinity) of different b2-microglobulin conformations characterized by dye affinity capillary electrophoresis J. Chromatogr., A 2000, 894, 319-327
21. Heegaard, N. H. H.; Sen, J. W.; Kaarsholm, N. C.; Nissen, M. H. Conformational intermediate of the amyloidogenic protein beta 2-microglobulin at neutral pH J. Biol. Chem. 2001, 276 (35) 32657-32662
22. Heegaard, N. H. H.; Roepstorff, P.; Melberg, S. G.; Nissen, M. H. Cleaved beta 2-microglobulin partially attains a conformation that has amyloidogenic features J. Biol. Chem. 2002, 277 (13) 11184-11189
23. Bagriantsev, S. N.; Kushnirov, V. V.; Liebman, S. W. Analysis of amyloid aggregates using agarose gel electrophoresis Methods Enzymol. 2006, 412 (33-48) 33-48
24. Miranda, E.; MacLeod, I.; Davies, M. J.; Perez, J.; Romisch, K.; Crowther, D. C.; Lomas, D. A. The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB Hum. Mol. Genet. 2008, 17 (11) 1527-1539
25. Wittig, I.; Beckhaus, T.; Wumaier, Z.; Karas, M.; Schagger, H. Mass estimation of native proteins by blue native electrophoresis: principles and practical hints Mol. Cell. Proteomics 2010, 9 (10) 2149-2161
26. Coalier, K. A.; Paranjape, G. S.; Karki, S.; Nichols, M. R. Stability of early-stage amyloid-beta(1-42) aggregation species Biochim. Biophys. Acta 2012, 1834 (1) 65-70
27. Mc Donald, J. M.; Savva, G. M.; Brayne, C.; Welzel, A. T.; Forster, G.; Shankar, G. M.; Selkoe, D. J.; Ince, P. G.; Walsh, D. M. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia Brain 2010, 133 (Pt 5) 1328-1341
28. Rekas, A.; Knott, R. B.; Sokolova, A.; Barnham, K. J.; Perez, K. A.; Masters, C. L.; Drew, S. C.; Cappai, R.; Curtain, C. C.; Pham, C. L. The structure of dopamine induced alpha-synuclein oligomers Eur. Biophys. J. 2010, 39 (10) 1407-1419
29. Wang, W.; Perovic, I.; Chittuluru, J.; Kaganovich, A.; Nguyen, L. T.; Liao, J.; Auclair, J. R.; Johnson, D.; Landeru, A.; Simorellis, A. K.; Ju, S.; Cookson, M. R.; Asturias, F. J.; Agar, J. N.; Webb, B. N.; Kang, C.; Ringe, D.; Petsko, G. A.; Pochapsky, T. C.; Hoang, Q. Q. A soluble alpha-synuclein construct forms a dynamic tetramer Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (43) 17797-17802
30. Tonoki, A.; Kuranaga, E.; Ito, N.; Nekooki-Machida, Y.; Tanaka, M.; Miura, M. Aging causes distinct characteristics of polyglutamine amyloids in vivo Genes Cells 2011, 16 (5) 557-564
31. Heegaard, N. H. H.; Jørgensen, T. J. D.; Rozlosnik, N.; Corlin, D. B.; Pedersen, J. S.; Tempesta, A. G.; Roepstorff, P.; Bauer, R.; Nissen, M. H. Unfolding, Aggregation, and Seeded Amyloid Formation of Lysine-58-Cleaved b2-microglobulin Biochemistry 2005, 44, 4397-4407
32. Jan, A.; Gokce, O.; Luthi-Carter, R.; Lashuel, H. A. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity J. Biol. Chem. 2008, 283 (42) 28176-28189
33. Walsh, D. M.; Lomakin, A.; Benedek, G. B.; Condron, M. M. Amyloid b-protein fibrillogenesis. Detection of a protofibrillar intermediate J. Biol. Chem. 1997, 272, 22364-22372
34. Walsh, D. M.; Hartley, D. M.; Kusumoto, Y.; Fezoui, Y.; Condron, M. M.; Lomakin, A.; Benedek, G. B.; Selkoe, D. J.; Teplow, D. B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates J. Biol. Chem. 1999, 274 (36) 25945-25952
35. Welzel, A. T.; Williams, A. D.; McWilliams-Koeppen, H. P.; Acero, L.; Weber, A.; Blinder, V.; Mably, A.; Bunk, S.; Hermann, C.; Farrell, M. A.; Ehrlich, H. J.; Schwarz, H. P.; Walsh, D. M.; Solomon, A.; O'Nuallain, B. Human Anti-Abeta IgGs Target Conformational Epitopes on Synthetic Dimer Assemblies and the AD Brain-Derived Peptide PLoS ONE 2012, 7 (11) e50317
36. Podlisny, M. B.; Walsh, D. M.; Amarante, P.; Ostaszewski, B. L.; Stimson, E. R.; Maggio, J. E.; Teplow, D. B.; Selkoe, D. J. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red Biochemistry 1998, 37 (11) 3602-3611
37. Fauvet, B.; Mbefo, M. K.; Fares, M. B.; Desobry, C.; Michael, S.; Ardah, M. T.; Tsika, E.; Coune, P.; Prudent, M.; Lion, N.; Eliezer, D.; Moore, D. J.; Schneider, B.; Aebischer, P.; El-Agnaf, O. M.; Masliah, E.; Lashuel, H. A. alpha-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer J. Biol. Chem. 2012, 287 (19) 15345-15364
38. Bartels, T.; Choi, J. G.; Selkoe, D. J. alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation Nature 2011, 477 (7362) 107-110
39. Cantor, C. R.; Schimmel, P. R. Biophysical Chemistry. Part II: Techniques for the Study of Biological Structure and Function, 1 st ed.; W. H. Freeman and Company: New York, 1980.
40. Brown, P. H.; Balbo, A.; Schuck, P. Characterizing Protein-Protein Interactions by Sedimentation Velocity Analytical Ultracentrifugation, Vol. 81; Current Protocols in Immunology; John Wiley and Sons: New York, 2008; 18.15.1-18.15.39. DOI: 10.1002/0471142735.im1815s81.
41. Gabrielson, J. P.; Arthur, K. K.; Stoner, M. R.; Winn, B. C.; Kendrick, B. S.; Razinkov, V.; Svitel, J.; Jiang, Y.; Voelker, P. J.; Fernandes, C. A.; Ridgeway, R. Precision of protein aggregation measurements by sedimentation velocity analytical ultracentrifugation in biopharmaceutical applications Anal. Biochem. 2010, 396 (2) 231-241
42. Balbo, A.; Brown, P. H.; Braswell, E. H.; Schuck, P. Measuring Protein-Protein Interactions by Equilibrium Sedimentation; Current Protocols in Immunology, Vol. 79; John Wiley and Sons: New York, 2007; 18.8.1-18.8.28. DOI: 10.1002/0471142735.im1808s79.
43. van den Heuvel, R. H.; Heck, A. J. Native protein mass spectrometry: from intact oligomers to functional machineries Curr. Opin. Chem. Biol. 2004, 8 (5) 519-526
44. Heck, A. J.; van den Heuvel, R. H. Investigation of intact protein complexes by mass spectrometry Mass Spectrom. Rev. 2004, 23 (5) 368-389
45. Caprioli, R. M.; Farmer, T. B.; Gile, J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS Anal. Chem. 1997, 69 (23) 4751-4760
46. Luxembourg, S. L.; Mize, T. H.; McDonnell, L. A.; Heeren, R. M. High-spatial resolution mass spectrometric imaging of peptide and protein distributions on a surface Anal. Chem. 2004, 76 (18) 5339-5344
47. Stoeckli, M.; Knochenmuss, R.; McCombie, G.; Mueller, D.; Rohner, T.; Staab, D.; Wiederhold, K. H. MALDI MS imaging of amyloid Methods Enzymol. 2006, 412, 94-106
48. Ferguson, C. N.; Benchaar, S. A.; Miao, Z.; Loo, J. A.; Chen, H. Direct ionization of large proteins and protein complexes by desorption electrospray ionization-mass spectrometry Anal. Chem. 2011, 83 (17) 6468-6473
49. Light-Wahl, K. J.; Schwartz, B. L.; Smith, R. D. Observation of the noncovalent quaternary associations of proteins by electrospray ionization mass spectrometry J. Am. Chem. Soc. 1994, 116, 5271-5278
50. Frimpong, A. K.; Abzalimov, R. R.; Uversky, V. N.; Kaltashov, I. A. Characterization of intrinsically disordered proteins with electrospray ionization mass spectrometry: conformational heterogeneity of alpha-synuclein Proteins 2010, 78 (3) 714-722
51. Bacher, G.; Szymanski, W. W.; Kaufman, S. L.; Zollner, P.; Blaas, D.; Allmaier, G. Charge-reduced nano electrospray ionization combined with differential mobility analysis of peptides, proteins, glycoproteins, noncovalent protein complexes and viruses J. Mass Spectrom. 2001, 36 (9) 1038-1052
52. Woods, L. A.; Radford, S. E.; Ashcroft, A. E. Advances in ion mobility spectrometry-mass spectrometry reveal key insights into amyloid assembly Biochim. Biophys. Acta 2012, 12, 10
53. Karasek, F. W. Plasma Chromatography Anal. Chem. 1974, 46 (8) 710A-720A
54. Vlad, C.; Iurascu, M. I.; Slamnoiu, S.; Hengerer, B.; Przybylski, M. Characterization of oligomerization-aggregation products of neurodegenerative target proteins by ion mobility mass spectrometry Methods Mol. Biol. 2012, 896, 399-412 10.1007/978-1-4614-3704-8-27
55. Gessel, M. M.; Bernstein, S.; Kemper, M.; Teplow, D. B.; Bowers, M. T. Familial Alzheimer's Disease Mutations Differentially Alter Amyloid beta-Protein Oligomerization ACS Chem. Neurosci. 2012, 3 (11) 909-918
56. Kloniecki, M.; Jablonowska, A.; Poznanski, J.; Langridge, J.; Hughes, C.; Campuzano, I.; Giles, K.; Dadlez, M. Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Abeta1-40 peptide oligomers J. Mol. Biol. 2011, 407 (1) 110-124
57. Bernstein, S. L.; Dupuis, N. F.; Lazo, N. D.; Wyttenbach, T.; Condron, M. M.; Bitan, G.; Teplow, D. B.; Shea, J. E.; Ruotolo, B. T.; Robinson, C. V.; Bowers, M. T. Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease Nat. Chem. 2009, 1 (4) 326-331
58. Bernstein, S. L.; Liu, D.; Wyttenbach, T.; Bowers, M. T.; Lee, J. C.; Gray, H. B.; Winkler, J. R. Alpha-synuclein: stable compact and extended monomeric structures and pH dependence of dimer formation J. Am. Soc. Mass Spectrom. 2004, 15 (10) 1435-1443
59. Bleiholder, C.; Dupuis, N. F.; Wyttenbach, T.; Bowers, M. T. Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to beta-sheet in amyloid fibril formation Nat. Chem. 2011, 3 (2) 172-177
60. Zheng, X.; Gessel, M. M.; Wisniewski, M. L.; Viswanathan, K.; Wright, D. L.; Bahr, B. A.; Bowers, M. T. Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Abeta42 protein J. Biol. Chem. 2012, 287 (9) 6084-6088
61. Gessel, M. M.; Wu, C.; Li, H.; Bitan, G.; Shea, J. E.; Bowers, M. T. Abeta(39-42) modulates Abeta oligomerization but not fibril formation Biochemistry. 2012, 51 (1) 108-117
62. Del, M. C.; Greenbaum, E. A.; Mayne, L.; Englander, S. W.; Woods, V. L., Jr. Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (43) 15477-15482
63. Vilar, M.; Chou, H. T.; Luhrs, T.; Maji, S. K.; Riek-Loher, D.; Verel, R.; Manning, G.; Stahlberg, H.; Riek, R. The fold of alpha-synuclein fibrils Proc. Natl. Acad. Sci. U.S.A 2008, 105 (25) 8637-8642
64. Carulla, N.; Caddy, G. L.; Hall, D. R.; Zurdo, J.; Gairi, M.; Feliz, M.; Giralt, E.; Robinson, C. V.; Dobson, C. M. Molecular recycling within amyloid fibrils Nature 2005, 436 (7050) 554-558
65. Carulla, N.; Zhou, M.; Giralt, E.; Robinson, C. V.; Dobson, C. M. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange Acc. Chem. Res. 2010, 43 (8) 1072-1079
66. Mahler, H. C.; Friess, W.; Grauschopf, U.; Kiese, S. Protein aggregation: pathways, induction factors and analysis J. Pharm. Sci. 2009, 98 (9) 2909-2934
67. Harper, J. D.; Lansbury, P. T., Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 1997, 66, 385-407
68. Flyvbjerg, H.; Jobs, E.; Leibler, S. Kinetics of self-assembling microtubules: an "inverse problem" in biochemistry Proc. Natl. Acad. Sci. U.S.A 1996, 93 (12) 5975-5979
69. Pedersen, J. T.; Hureau, C.; Hemmingsen, L.; Heegaard, N. H.; ØStergaard, J.; Vasak, M.; Faller, P. Rapid Exchange of Metal between Zn(7)-Metallothionein-3 and Amyloid-beta Peptide Promotes Amyloid-Related Structural Changes Biochemistry 2012, 51 (8) 1697-1706
70. Hoyer, W.; Antony, T.; Cherny, D.; Heim, G.; Jovin, T. M.; Subramaniam, V. Dependence of alpha-synuclein aggregate morphology on solution conditions J. Mol. Biol. 2002, 322 (2) 383-393
71. Berne, B. J.; Pecora, R. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics; Dover Publications: Mineola, NY, 2000.
72. Lomakin, A.; Teplow, D. B. Quasielastic light scattering study of amyloid beta-protein fibrillogenesis Methods Mol. Biol. 2012, 849, 69-83 10.1007/978-1-61779-551-0-6
73. Philo, J. S. A critical review of methods for size characterization of non-particulate protein aggregates Curr. Pharm. Biotechnol. 2009, 10 (4) 359-372
74. Lomakin, A.; Chung, D. S.; Benedek, G. B.; Kirschner, D. A.; Teplow, D. B. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants Proc. Natl. Acad. Sci. U.S.A 1996, 93 (3) 1125-1129
75. Kusumoto, Y.; Lomakin, A.; Teplow, D. B.; Benedek, G. B. Temperature dependence of amyloid beta-protein fibrillization Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (21) 12277-12282
76. Yamin, G.; Glaser, C. B.; Uversky, V. N.; Fink, A. L. Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein J. Biol. Chem. 2003, 278 (30) 27630-27635
77. Georgalis, Y.; Starikov, E. B.; Hollenbach, B.; Lurz, R.; Scherzinger, E.; Saenger, W.; Lehrach, H. Wanker, E. E. Huntingtin aggregation monitored by dynamic light scattering Proc. Natl. Acad. Sci. U.S.A 1998, 95 (11) 6118-6121
78. Frid, P.; Anisimov, S. V.; Popovic, N. Congo red and protein aggregation in neurodegenerative diseases Brain Res. Rev. 2007, 53 (1) 135-160
79. Nilsson, M. R. Techniques to study amyloid fibril formation in vitro Methods 2004, 34 (1) 151-160
80. Lorenzo, A.; Yankner, B. A. b-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 12243-12247
81. Poirier, M. A.; Li, H.; Macosko, J.; Cai, S.; Amzel, M.; Ross, C. A. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization J. Biol. Chem. 2002, 277 (43) 41032-41037
82. Zhao, J. H.; Liu, H. L.; Elumalai, P.; Chen, W. H.; Men, L. C.; Liu, K. T. Molecular modeling to investigate the binding of Congo red toward GNNQQNY protofibril and in silico virtual screening for the identification of new aggregation inhibitors J. Mol. Model. 2013, 19 (1) 151-162
83. Groenning, M. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status J. Chem. Biol. 2010, 3 (1) 1-18
84. LeVine, H. Thioflavine T interaction with synthetic Alzheimer's disease b-amyloid peptides: Detection of amyloid aggregation in solution Protein Sci. 1993, 2, 404-410
85. De Ferrari, G. V.; Mallender, W. D.; Inestrosa, N. C.; Rosenberry, T. L. Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites J. Biol. Chem. 2001, 276 (26) 23282-23287
86. Fodera, V.; Librizzi, F.; Groenning, M.; van de Weert, M.; Leone, M. Secondary nucleation and accessible surface in insulin amyloid fibril formation J. Phys. Chem. B 2008, 112 (12) 3853-3858
87. Cheng, P. N.; Liu, C.; Zhao, M.; Eisenberg, D.; Nowick, J. S. Amyloid beta-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity Nat. Chem. 2012, 4 (11) 927-933
88. Bladen, H. A.; Nylen, M. U.; Glenner, G. G. The ultrastructure of human amyloid as revealed by the negative staining technique J. Ultrastruct. Res. 1966, 14, 449-459
89. Cohen, A. S.; Calkins, E. Electron microscopic observations on a fibrous component in amyloid of diverse origins Nature 1959, 183, 1202-1203
90. Lashuel, H. A.; Wall, J. S. Molecular electron microscopy approaches to elucidating the mechanisms of protein fibrillogenesis Methods Mol. Biol. 2005, 299, 81-101
91. Li, H.; Rahimi, F.; Sinha, S.; Maiti, P.; Bitan, G.; Murakami, K. Amyloids and Protein Aggregation-Analytical Methods. In Encyclopedia of Analytical Chemistry; Meyers, R. A., Ed.; John Wiley & Sons Ltd.: Chichester, U.K., 2009; pp 1-32.
92. Schmidt, M.; Sachse, C.; Richter, W.; Xu, C.; Fandrich, M.; Grigorieff, N. Comparison of Alzheimer Abeta(1-40) and Abeta(1-42) amyloid fibrils reveals similar protofilament structures Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (47) 19813-19818
93. Saibil, H. R.; Seybert, A.; Habermann, A.; Winkler, J.; Eltsov, M.; Perkovic, M.; Castano-Diez, D.; Scheffer, M. P.; Haselmann, U.; Chlanda, P.; Lindquist, S.; Tyedmers, J.; Frangakis, A. S. Heritable yeast prions have a highly organized three-dimensional architecture with interfiber structures Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (37) 14906-14911
94. Meinhardt, J.; Sachse, C.; Hortschansky, P.; Grigorieff, N.; Fandrich, M. Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils J. Mol. Biol. 2009, 386 (3) 869-877
95. Gras, S. L.; Waddington, L. J.; Goldie, K. N. Transmission electron microscopy of amyloid fibrils Methods Mol. Biol. 2011, 752, 197-214 10.1007/978-1-60327-223-0-13
96. Miller, Y.; Ma, B.; Tsai, C. J.; Nussinov, R. Hollow core of Alzheimer's Abeta42 amyloid observed by cryoEM is relevant at physiological pH Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (32) 14128-14133
97. Sachse, C.; Grigorieff, N.; Fandrich, M. Nanoscale flexibility parameters of Alzheimer amyloid fibrils determined by electron cryo-microscopy Angew. Chem., Int. Ed. 2010, 49 (7) 1321-1323
98. Irving, J. A.; Ekeowa, U. I.; Belorgey, D.; Haq, I.; Gooptu, B.; Miranda, E.; Perez, J.; Roussel, B. D.; Ordonez, A.; Dalton, L. E.; Thomas, S. E.; Marciniak, S. J.; Parfrey, H.; Chilvers, E. R.; Teckman, J. H.; Alam, S.; Mahadeva, R.; Rashid, S. T.; Vallier, L.; Lomas, D. A. The serpinopathies studying serpin polymerization in vivo Methods Enzymol. 2011, 501, 421-466 10.1016/B978-0-12-385950-1.00018-3
99. Fauerbach, J. A.; Yushchenko, D. A.; Shahmoradian, S. H.; Chiu, W.; Jovin, T. M.; Jares-Erijman, E. A. Supramolecular non-amyloid intermediates in the early stages of alpha-synuclein aggregation Biophys. J. 2012, 102 (5) 1127-1136
100. Wall, J. S.; Simon, M. N.; Lin, B. Y.; Vinogradov, S. N. Mass mapping of large globin complexes by scanning transmission electron microscopy Methods Enzymol. 2008, 436, 487-501 10.1016/S0076-6879(08)36027-3
101. Goldsbury, C.; Green, J. Time-lapse atomic force microscopy in the characterization of amyloid-like fibril assembly and oligomeric intermediates Methods Mol. Biol. 2005, 299, 103-128
102. Gosal, W. S.; Myers, S. L.; Radford, S. E.; Thomson, N. H. Amyloid under the atomic force microscope Protein Pept. Lett. 2006, 13 (3) 261-270
103. Serem, W. K.; Bett, C. K.; Ngunjiri, J. N.; Garno, J. C. Studies of the growth, evolution, and self-aggregation of beta-amyloid fibrils using tapping-mode atomic force microscopy Microsc. Res. Tech. 2011, 74 (7) 699-708
104. Murphy, R. M. Peptide aggregation in neurodegenerative disease. Annu. Rev. Biomed. Eng. 2002, 4:., 155-174.
105. Lyubchenko, Y. L.; Krasnoslobodtsev, A. V.; Luca, S. Fibrillogenesis of huntingtin and other glutamine containing proteins Subcell. Biochem. 2012, 65, 225-251 10.1007/978-94-007-5416-4-10
106. Skora, L.; Fonseca-Ornelas, L.; Hofele, R. V.; Riedel, D.; Giller, K.; Watzlawik, J.; Schulz-Schaeffer, W. J.; Urlaub, H.; Becker, S.; Zweckstetter, M. Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants J. Biol. Chem. 2013, 288 (5) 2994-3002
107. Chou, J. J.; Sounier, R. Solution nuclear magnetic resonance spectroscopy Methods Mol. Biol. 2013, 955 (495-517) 495-517 10.1007/978-1-62703-176-9-26
108. Tamiola, K.; Mulder, F. A. Using NMR chemical shifts to calculate the propensity for structural order and disorder in proteins Biochem. Soc. Trans. 2012, 40 (5) 1014-1020
109. Hou, L.; Shao, H.; Zhang, Y.; Li, H.; Menon, N. K.; Neuhaus, E. B.; Brewer, J. M.; Byeon, I. J.; Ray, D. G.; Vitek, M. P.; Iwashita, T.; Makula, R. A.; Przybyla, A. B.; Zagorski, M. G. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation J. Am. Chem. Soc. 2004, 126 (7) 1992-2005
110. Fawzi, N. L.; Ying, J.; Torchia, D. A.; Clore, G. M. Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation J. Am. Chem. Soc. 2010, 132 (29) 9948-9951
111. Fawzi, N. L.; Ying, J.; Ghirlando, R.; Torchia, D. A.; Clore, G. M. Atomic-resolution dynamics on the surface of amyloid-beta protofibrils probed by solution NMR Nature 2011, 480 (7376) 268-272
112. Pedersen, J. T.; Teilum, K.; Heegaard, N. H.; OStergaard, J.; Adolph, H. W.; Hemmingsen, L. Rapid formation of a preoligomeric peptide-metal-peptide complex following copper(II) binding to amyloid beta peptides Angew. Chem., Int. Ed. 2011, 50 (11) 2532-2535
113. Tycko, R. Molecular structure of amyloid fibrils: insights from solid-state NMR Q. Rev. Biophys. 2006, 39 (1) 1-55
114. Petkova, A. T.; Ishii, Y.; Balbach, J. J.; Antzutkin, O. N.; Leapman, R. D.; Delaglio, F.; Tycko, R. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (26) 16742-16747
115. Heise, H.; Hoyer, W.; Becker, S.; Andronesi, O. C.; Riedel, D.; Baldus, M. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (44) 15871-15876
116. Walsh, P.; Simonetti, K.; Sharpe, S. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein Structure 2009, 17 (3) 417-426
117. Paravastu, A. K.; Qahwash, I.; Leapman, R. D.; Meredith, S. C.; Tycko, R. Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (18) 7443-7448
118. Funke, S. A.; Birkmann, E.; Henke, F.; Gortz, P.; Lange-Asschenfeldt, C.; Riesner, D.; Willbold, D. Single particle detection of Abeta aggregates associated with Alzheimer's disease Biochem. Biophys. Res. Commun. 2007, 364 (4) 902-907
119. Funke, S. A.; Wang, L.; Birkmann, E.; Willbold, D. Single-particle detection system for Abeta aggregates: adaptation of surface-fluorescence intensity distribution analysis to laser scanning microscopy Rejuvenation Res. 2010, 13 (2-3) 206-209
120. Hubinger, S.; Bannach, O.; Funke, S. A.; Willbold, D.; Birkmann, E. Detection of alpha-synuclein aggregates by fluorescence microscopy Rejuvenation. Res. 2012, 15 (2) 213-216
121. Kayed, R.; Head, E.; Sarsoza, F.; Saing, T.; Cotman, C. W.; Necula, M.; Margol, L.; Wu, J.; Breydo, L.; Thompson, J. L.; Rasool, S.; Gurlo, T.; Butler, P.; Glabe, C. G. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Mol. Neurodegener. 2007, 2, 18
122. Kayed, R.; Head, E.; Thompson, J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W.; Glabe, C. G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 2003, 300 (5618) 486-489
123. Portelius, E.; Brinkmalm, G.; Tran, A.; Andreasson, U.; Zetterberg, H.; Westman-Brinkmalm, A.; Blennow, K.; Ohrfelt, A. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid Exp. Neurol. 2010, 223 (2) 351-358
124. Ohrfelt, A.; Zetterberg, H.; Andersson, K.; Persson, R.; Secic, D.; Brinkmalm, G.; Wallin, A.; Mulugeta, E.; Francis, P. T.; Vanmechelen, E.; Aarsland, D.; Ballard, C.; Blennow, K.; Westman-Brinkmalm, A. Identification of novel alpha-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method Neurochem. Res. 2011, 36 (11) 2029-2042
125. Kunst, C. B.; Mezey, E.; Brownstein, M. J.; Patterson, D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions Nat. Genet. 1997, 15 (1) 91-94